Soyoung's Feed
Oct 30, 2014

Exclusive: Sale of yearbook maker Herff Jones parent for $1.5 billion near – sources

By Soyoung Kim, Olivia Oran and Greg Roumeliotis

(Reuters) – The parent company of yearbook and class ring maker Herff Jones is close to selling itself to a private equity consortium led by Charlesbank Capital Partners for about $1.5 billion, according to people familiar with the matter.

Herff Jones is also known for making the Super Bowl XLI rings for the Indianapolis Colts.

Oct 30, 2014

Sale of yearbook maker Herff Jones parent for $1.5 bln near-sources

Oct 30 (Reuters) – The parent company of yearbook and class ring maker Herff Jones is close to selling itself to a private equity consortium led by Charlesbank Capital Partners for about $1.5 billion, according to people familiar with the matter.

Herff Jones is also known for making the Super Bowl XLI rings for the Indianapolis Colts.

Oct 22, 2014

Humana looks to sell urgent care subsidiary Concentra -sources

Oct 22 (Reuters) – Health insurer Humana Inc is
exploring a sale of its urgent care subsidiary Concentra in a
deal that could value it at around $1 billion, according to
three people familiar with the matter.

The effort to sell Concentra comes less than four years
after the unit was acquired. It indicates that Humana, one of
the largest providers of Medicare plans for the elderly in the
United States, has faced challenges in trying to run healthcare
centers itself in order to better manage medical costs.

Oct 17, 2014

CF Industries, Yara International end merger talks

Oct 16 (Reuters) – CF Industries Holdings Inc ended
merger talks with Norway’s Yara International ASA after
the companies failed to agree on terms of a deal that would have
created a global fertilizer concern with an enterprise value
approaching $30 billion.

Chicago-based CF and Yara said last month they were in
early-stage talks about a “merger of equals” that would
challenge the world’s largest fertilizer producer, Canada’s
Potash Corp of Saskatchewan, in an oversupplied and
fragmented market.

Oct 16, 2014

Timken, Regal Beloit, Altra vying for Emerson power unit -sources

Oct 16 (Reuters) – Timken Co, Regal Beloit Corp
and Altra Industrial Motion Corp are among
those competing for Emerson Electric Co’s power
transmission solutions business, according to people familiar
with the matter.

Ball bearings maker Timken, electric motors manufacturer
Regal Beloit, and Altra Industrial Motion, a producer of brakes,
clutches and couplings, are through to the second round of
bidding in the auction for the unit, the people said this week.

Oct 10, 2014

Exclusive: Car care products company Armored AutoGroup mulls IPO – sources

NEW YORK (Reuters) – Armored AutoGroup Inc is exploring an initial public offering that could value the maker of car care products at more than $1.5 billion, including debt, according to people familiar with the matter.

Armored AutoGroup’s owner, private equity firm Avista Capital Partners, is in talks with investment banks, including JPMorgan Chase & Co (JPM.N: Quote, Profile, Research, Stock Buzz), about the potential offering, the people said this week.

Oct 10, 2014

Car care products company Armored AutoGroup mulls IPO-sources

NEW YORK, Oct 10 (Reuters) – Armored AutoGroup Inc is
exploring an initial public offering that could value the maker
of car care products at more than $1.5 billion, including debt,
according to people familiar with the matter.

Armored AutoGroup’s owner, private equity firm Avista
Capital Partners, is in talks with investment banks, including
JPMorgan Chase & Co, about the potential offering, the
people said this week.

Oct 10, 2014

Exclusive: Top Actavis holder, Fidelity, adds Allergan holdings- sources

NEW YORK/BOSTON (Reuters) – Fidelity Investments, the largest shareholder in Actavis Plc (ACT.N: Quote, Profile, Research, Stock Buzz), has increased its holdings in takeover-target Allergan (AGN.N: Quote, Profile, Research, Stock Buzz) in recent months and would be supportive of a potential merger between the two drugmakers, according to people familiar with the matter.

The Boston-based investment firm, which collectively owned 3.88 million Allergan shares through several of its funds as of end-June, had added roughly 2 million shares by the end of August, according to Thomson Reuters data based on Fidelity’s monthly filings.

Oct 10, 2014

Top Actavis holder, Fidelity, adds Allergan holdings-sources

NEW YORK/BOSTON, Oct 10 (Reuters) – Fidelity Investments,
the largest shareholder in Actavis Plc, has increased
its holdings in takeover-target Allergan in recent
months and would be supportive of a potential merger between the
two drugmakers, according to people familiar with the matter.

The Boston-based investment firm, which collectively owned
3.88 million Allergan shares through several of its funds as of
end-June, had added roughly 2 million shares by the end of
August, according to Thomson Reuters data based on Fidelity’s
monthly filings.

Oct 8, 2014

Actavis may reap benefits of Valeant’s hard work on Allergan

NEW YORK, Oct 8 (Reuters) – Earlier this week, Canada’s
Valeant Pharmaceuticals International Inc appeared to
have its plan to buy Botox maker Allergan Inc all mapped
out.

The next phase in Valeant’s months-long campaign to acquire
Allergan for about $53 billion in cash and stock was to
announce “blow-out” earnings on Oct. 20, which would have led to
a jump in its share price and, therefore, the value of its bid,
according to people familiar with the situation.